This month, Axial Biotherapeutics announced the appointment of leading experts in the Autism Spectrum Disorders (ASD) field to its...

Read more

We are proud to announce that Kairos Venture Partners II, L.P., our second fund, has made its second investment...

Read more
By: Kairos Ventures On: July 19, 2017 In: 3D Bio, Kairos II, Portfolio News

We are excited to announce that Kairos Venture Partners II, L.P., our second fund, has made its first investment...

Read more
By: Kairos Ventures On: June 25, 2017 In: Kairos News

We would like to welcome six new team members to Kairos Ventures: Danielle Walker, Chris Del Vecchio and Shahed...

Read more
By: Kairos Ventures On: June 22, 2017 In: Compellon, Portfolio News

Kairos portfolio company, Compellon, appointed software and services veteran Carv Moore as its Chief Executive Officer to lead the...

Read more
By: Kairos Ventures On: June 15, 2017 In: Delpor

The NIDDK continues to fund Delpor's efforts to utilize its NANOPOR™ technology in developing a matchstick-size subcutaneous implant device...

Read more
By: Kairos Ventures On: June 11, 2017 In: Kairos News

We are happy to announce that Travis Blake has joined the Kairos team as the Principal for Physical Sciences,...

Read more
By: Kairos Ventures On: May 31, 2017 In: Delpor, Portfolio News

Delpor will be part of the Innovation Zone, a high profile 6,000 square foot exhibit space dedicated to showcasing...

Read more
By: Kairos Ventures On: May 9, 2017 In: Holoclara, Portfolio News

This Seed funding allows Holoclara to continue development of their immunotherapy to bring relief to millions of people suffering...

Read more
By: Kairos Ventures On: March 22, 2017 In: Neuro-Bio, Portfolio News

We are pleased to announce that Neuro-Bio is the latest company to join the Kairos portfolio, following our investment...

Read more